LIGAND PHARMACEUTICAL INC (LGNXZ)
USD 0.0
(-63.33%)
USD 0.0
(-63.33%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 5.75 Million USD | 0.0% |
| 2022 | - USD | -100.0% |
| 2021 | 320.71 Million USD | -27.49% |
| 2020 | 442.29 Million USD | -30.78% |
| 2019 | 638.95 Million USD | 4.77% |
| 2018 | 609.86 Million USD | 3133.81% |
| 2017 | 18.85 Million USD | -36.21% |
| 2016 | 29.56 Million USD | -25.4% |
| 2015 | 39.62 Million USD | -80.21% |
| 2014 | 200.23 Million USD | 6420.03% |
| 2013 | 3.07 Million USD | -48.5% |
| 2012 | 5.96 Million USD | -28.73% |
| 2011 | 8.36 Million USD | -24.74% |
| 2010 | 11.11 Million USD | 0.0% |
| 2009 | - USD | -100.0% |
| 2008 | 2.17 Million USD | 247.37% |
| 2007 | 627 Thousand USD | -70.92% |
| 2006 | 2.15 Million USD | -98.73% |
| 2005 | 170.17 Million USD | -0.54% |
| 2004 | 171.09 Million USD | 0.0% |
| 2003 | - USD | -100.0% |
| 2002 | 33.63 Million USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 6.41 Million USD | 23.58% |
| 2024 Q1 | 5.19 Million USD | -9.8% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q4 | 5.75 Million USD | 0.0% |
| 2023 FY | 5.75 Million USD | 0.0% |
| 2022 Q1 | 176.54 Million USD | -44.95% |
| 2022 FY | - USD | -100.0% |
| 2022 Q2 | 144.56 Million USD | -18.11% |
| 2022 Q4 | - USD | -100.0% |
| 2022 Q3 | 76.6 Thousand USD | -99.95% |
| 2021 Q2 | 315.31 Million USD | -10.5% |
| 2021 Q1 | 352.31 Million USD | -21.68% |
| 2021 FY | 320.71 Million USD | -27.49% |
| 2021 Q4 | 320.71 Million USD | 1.21% |
| 2021 Q3 | 316.88 Million USD | 0.5% |
| 2020 Q4 | 449.82 Million USD | -1.98% |
| 2020 Q1 | 453.66 Million USD | -30.09% |
| 2020 Q2 | 458.85 Million USD | 1.14% |
| 2020 Q3 | 458.89 Million USD | 0.01% |
| 2020 FY | 442.29 Million USD | -30.78% |
| 2019 Q1 | 643.74 Million USD | 1.17% |
| 2019 Q4 | 648.92 Million USD | 1.16% |
| 2019 Q3 | 641.46 Million USD | -3.07% |
| 2019 FY | 638.95 Million USD | 4.77% |
| 2019 Q2 | 661.78 Million USD | 2.8% |
| 2018 Q4 | 636.29 Million USD | -22.02% |
| 2018 Q2 | 806.28 Million USD | 230.95% |
| 2018 Q1 | 243.62 Million USD | 0.1% |
| 2018 Q3 | 815.98 Million USD | 1.2% |
| 2018 FY | 609.86 Million USD | 3133.81% |
| 2017 Q2 | 242.92 Million USD | 0.09% |
| 2017 FY | 18.85 Million USD | -36.21% |
| 2017 Q4 | 243.38 Million USD | 0.1% |
| 2017 Q3 | 243.15 Million USD | 0.1% |
| 2017 Q1 | 242.69 Million USD | 0.09% |
| 2016 Q3 | 242.25 Million USD | 0.09% |
| 2016 FY | 29.56 Million USD | -25.4% |
| 2016 Q4 | 242.47 Million USD | 0.09% |
| 2016 Q2 | 242.03 Million USD | 18.27% |
| 2016 Q1 | 204.65 Million USD | -0.35% |
| 2015 Q2 | 3.19 Million USD | -14.97% |
| 2015 Q1 | 3.75 Million USD | -98.09% |
| 2015 FY | 39.62 Million USD | -80.21% |
| 2015 Q4 | 205.37 Million USD | 7376.23% |
| 2015 Q3 | 2.74 Million USD | -13.94% |
| 2014 Q3 | 4.73 Million USD | 198.11% |
| 2014 Q2 | 1.58 Million USD | -32.15% |
| 2014 Q1 | 2.33 Million USD | -23.84% |
| 2014 FY | 200.23 Million USD | 6420.03% |
| 2014 Q4 | 196.84 Million USD | 4060.68% |
| 2013 FY | 3.07 Million USD | -48.5% |
| 2013 Q2 | 4.3 Million USD | -15.16% |
| 2013 Q3 | 3.72 Million USD | -13.47% |
| 2013 Q1 | 5.07 Million USD | -14.91% |
| 2013 Q4 | 3.07 Million USD | -17.56% |
| 2012 Q1 | 7.71 Million USD | -7.78% |
| 2012 FY | 5.96 Million USD | -28.73% |
| 2012 Q2 | 7.35 Million USD | -4.68% |
| 2012 Q3 | 6.53 Million USD | -11.16% |
| 2012 Q4 | 5.96 Million USD | -8.74% |
| 2011 Q3 | 9.17 Million USD | -7.0% |
| 2011 Q1 | 10.54 Million USD | -5.13% |
| 2011 Q2 | 9.86 Million USD | -6.51% |
| 2011 Q4 | 8.36 Million USD | -8.77% |
| 2011 FY | 8.36 Million USD | -24.74% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | 11.11 Million USD | 0.0% |
| 2010 Q4 | 11.11 Million USD | 0.0% |
| 2009 FY | - USD | -100.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q3 | - USD | -100.0% |
| 2009 Q2 | 25 Thousand USD | -53.7% |
| 2009 Q1 | 54 Thousand USD | -97.52% |
| 2008 Q4 | 2.17 Million USD | 1166.28% |
| 2008 Q3 | 172 Thousand USD | -35.34% |
| 2008 Q2 | 266 Thousand USD | -34.0% |
| 2008 Q1 | 403 Thousand USD | -35.73% |
| 2008 FY | 2.17 Million USD | 247.37% |
| 2007 Q2 | 1.25 Million USD | -23.28% |
| 2007 Q3 | 889 Thousand USD | -29.39% |
| 2007 Q4 | 627 Thousand USD | -29.47% |
| 2007 Q1 | 1.64 Million USD | -23.89% |
| 2007 FY | 627 Thousand USD | -70.92% |
| 2006 Q2 | 142.31 Million USD | -1.04% |
| 2006 Q4 | 2.15 Million USD | -98.48% |
| 2006 FY | 2.15 Million USD | -98.73% |
| 2006 Q3 | 142.07 Million USD | -0.17% |
| 2006 Q1 | 143.8 Million USD | -15.5% |
| 2005 Q3 | 170.19 Million USD | -0.37% |
| 2005 Q4 | 170.17 Million USD | -0.01% |
| 2005 FY | 170.17 Million USD | -0.54% |
| 2005 Q1 | 171.11 Million USD | 0.01% |
| 2005 Q2 | 170.82 Million USD | -0.17% |
| 2004 Q2 | 170.8 Million USD | -0.03% |
| 2004 Q1 | 170.84 Million USD | 0.0% |
| 2004 Q4 | 171.09 Million USD | 0.0% |
| 2004 FY | 171.09 Million USD | 0.0% |
| 2003 Q4 | - USD | -100.0% |
| 2003 Q1 | 158.95 Million USD | 84.54% |
| 2003 Q2 | 158.65 Million USD | -0.19% |
| 2003 FY | - USD | -100.0% |
| 2003 Q3 | 157.93 Million USD | -0.45% |
| 2002 Q2 | - USD | 0.0% |
| 2002 FY | 33.63 Million USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q3 | 3.73 Million USD | 0.0% |
| 2002 Q4 | 86.13 Million USD | 2208.01% |
| 2001 FY | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 312.15 Thousand USD | -1743.612% |
| Allstar Health Brands, Inc. | - USD | -Infinity% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 21.25 Thousand USD | -26979.804% |
| Café Serendipity Holdings, Inc. | - USD | -Infinity% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 254.07 Thousand USD | -2165.115% |
| HealthWarehouse.com, Inc. | 2.63 Million USD | -118.726% |
| MedGen, Inc. | - USD | -Infinity% |
| Omni Health, Inc. | 495.57 Thousand USD | -1061.27% |
| Oxford Investments Holdings Inc. | - USD | -Infinity% |
| Pineapple, Inc. | - USD | -Infinity% |
| ScripsAmerica, Inc. | 1.06 Million USD | -438.463% |